Pfizer awarded damages against Breuil
Pfizer Inc announced that the US District Court (North
Carolina) has awarded Embrex, part of Pfizer Animal Health, US$1,074,993.94 for
damages caused by the infringement of two of its US patents by Breuil S.A. and
New Tech Solutions, Inc.
The patents cover a method for distinguishing live from dead or infertile
poultry eggs using pulsed light methodology and then taking that information and
selectively injecting only eggs identified as suitable for inoculation. The
court also issued a permanent injunction against Breuil (Landivisiau, France)
and New Tech Solutions (Gainsville, GA, US) to prevent any further
Pfizer subsidiary, is an international agricultural biotechnology company
engaged in the development of innovative in ovo (in the egg) solutions that meet
the needs of today's global poultry industry.
The company's unique integration of several scientific and engineering
disciplines enables it to be the leading provider of in ovo, value-added
solutions with its automated injection device known as the InovojectÂ®
system and detection devices as well as its select
To comment, login here
Or register to be able to comment.